IntriCon Corporation (IIN)
| Market Cap | 196.87M |
| Revenue (ttm) | 113.04M |
| Net Income (ttm) | 169,000 |
| Shares Out | 8.99M |
| EPS (ttm) | 0.01 |
| PE Ratio | 1,700.00 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 16 |
| Last Price | $22.10 |
| Previous Close | $22.31 |
| Change ($) | -0.21 |
| Change (%) | -0.94% |
| Day's Open | 22.13 |
| Day's Range | 21.97 - 22.31 |
| Day's Volume | 4,418 |
| 52-Week Range | 9.95 - 28.16 |
IntriCon Corporation (IIN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
ARDEN HILLS, Minn., May 10, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering, manufacturing, and packaging miniature in...
ARDEN HILLS, Minn., April 26, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature intervention...
TTDKY vs. IIN: Which Stock Is the Better Value Option?
Shares of IntriCon (NASDAQ:IIN) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 50.00% year over year to $0.12, which beat the estimate...
ARDEN HILLS, Minn., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering, and manufacturing miniature intervention...
IntriCon Corporation (IIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ARDEN HILLS, Minn., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventiona...
ARDEN HILLS, Minn., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering, and manufacturing miniature intervention...
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment ...
IntriCon Corporation (IIN) CEO Scott Longval on Q3 2020 Results - Earnings Call Transcript
IntriCon (NASDAQ: IIN) unveils its next round of earnings this Monday, November 09. Get prepared with Benzinga's ultimate preview for IntriCon's Q3 earnings.
ARDEN HILLS, Minn., Oct. 26, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, t...
The 'Moneyball' system is the single best variable to achieve powerful stock gains. Let Louis Navellier show you how it works.
IntriCon Corporation (IIN) CEO Mark Gorder on Q2 2020 Results - Earnings Call Transcript
ARDEN HILLS, Minn., Aug. 10, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventio...
ARDEN HILLS, Minn., July 27, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices,...
J. Scott Longval to Succeed Mark Gorder as President and CEO, Effective October 1, 2020 J. Scott Longval to Succeed Mark Gorder as President and CEO, Effective October 1, 2020
IntriCon Corporation (IIN) CEO Mark Gorder on Q1 2020 Results - Earnings Call Transcript
ARDEN HILLS, Minn., May 19, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, ...
ARDEN HILLS, Minn., May 19, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, ...
ARDEN HILLS, Minn., April 30, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices...
Provides Preliminary First Quarter 2020 Results; Withdraws Full Year 2020 Guidance Provides Preliminary First Quarter 2020 Results; Withdraws Full Year 2020 Guidance
ARDEN HILLS, Minn., March 19, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN) , a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical device...
IntriCon Corporation (IIN) CEO Mark Gorder on Q4 2019 Results - Earnings Call Transcript
ARDEN HILLS, Minn., Dec. 02, 2019 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today ...
Economic uncertainty has made it difficult to pinpoint big-growth names. However, we uncovered three growth stocks to buy in order to beat the market.
IntriCon (IIN) CEO Mark Gorder on Q3 2019 Results - Earnings Call Transcript
IntriCon (IIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IntriCon (IIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IntriCon Corporation (IIN) CEO Mark Gorder on Q1 2019 Results - Earnings Call Transcript
About IIN
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. It offers micro-miniature products, microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components, and assemblies and software solutions for medical devices, hearing healthcare, and professional audio communication devices markets. The company also provides micro coils for surgical navigation clinical applications, such as ... [Read more...]
| Industry Medical Instruments & Supplies | Founded 1930 |
| CEO Mark Gorder | Employees 762 |
| Stock Exchange NASDAQ | Ticker Symbol IIN |
Financial Performance
In 2020, Intricon's revenue was $102.77 million, a decrease of -9.45% compared to the previous year's $113.49 million. Losses were -$2.52 million, -33.17% less than in 2019.
Analyst Forecasts
According to 3 analysts, the average rating for Intricon stock is "Strong Buy." The 12-month stock price forecast is 29.33, which is an increase of 32.71% from the latest price.